Igenomix India
Igenomix is a medical testing laboratory specializing in reproductive genetic services. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive. In 2021, Vitrolife acquired Igenomix, founded in 2011. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our vision is to enable people to fulfill the dream of having a healthy baby. Our mission is to be the leading global partner in reproductive health, striving for better treatment outcomes for patients. Together we create excellence in reproductive health. The Vitrolife AB (publ) share is listed on Nasdaq Stockholm.
Why ERA? Volume 3:Leveraging the comprehensive support and expertise behind ERA to optimize outcome
Why ERA? Volume 2 Exploring the unmatched precision of ERA to further maximize patient results
Why ERA? Volume 1 ERA, a proven solution for RIF
V3- Proper protocol compliance to optimize your clinic’s ERA outcomes
V2 - Proper protocol compliance to optimize clinic’s ERA outcomes
V1 - Proper protocol compliance to optimize your clinic’s ERA outcomes
Endometrial Receptivity Analysis (ERA) Test by Dr. Maria Ruiz
Embrace (niPGT-A) Talk by Dr. Carmen Rubio
Genomic Precision Diagnostic - by Igenomix
What is Genetic Counseling
GPDx (Introduction) - by Igenomix
Introduction for Diagnostic Testing
ERA - Endometrial Receptivity Analysis - IND - Nasser Al Asmar, PhD
Endometrial Receptivity Analysis (ERA) by Igenomix
Igenomix India - With science on your side
The endometrium matters : the EMMA and ALICE test YouTube 360p
Synchrony from Igenomix
What's the PGS PGT-A Test
What's the PGD PGT-M Test
Carrier Genetic Test (CGT) by Igenomix
Sperm Aneuploidy Test (SAT) by Igenomix
Oncodona by Igenomix
Product of Conception (POC) by Igenomix
ERA test by Dr Carlos Simon
Employing Igenomix's PGD and PGS Together Ensures Ongoing Pregnancy Rate of 42.9%
IGENOMIX Head Quarter corporate video
Early risk detection of hereditary breast and ovarian cancer: Oncodona by Igenomix
Implantation failures during IVF? Ask your doctor for ERA.
How to perform an endometrial liquid biopsy
Endometrial Liquid Biopsy what clinicians need to know